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SPARC (Secreted Protein Acidic and Rich in Cysteine) is a multifunctional glycoprotein belonging to a group of
matrix-associated factors that mediate cell-extracellular matrix interactions but have no structural roles. In the
present study we investigated the contribution of SPARC to factors that inﬂuence the development of skin tumors
in response to UV irradiation. A hairless SPARC-null mouse was developed and compared to control SKH1 hairless
mice in terms of skin tumor induction and extracellular matrix changes occurring in response to UV-irradiation.
Following 23 weeks of exposure to UVB totaling 14.5 J per cm2, tumor development in the wild-type mice was
severe, with an average of over 20 tumors per mouse, many of which were squamous cell carcinomas. Conversely,
the SPARC-null mice were strikingly tumor-resistant, developing no squamous cell carcinomas and averaging less
than one small papilloma per mouse. SPARC was undetectable immunohistochemically in skin from the non-
irradiated control group yet was present in relatively high quantities in the basal and superﬁcial areas of the tumor
mass. The SPARC-null mice also exhibited a limited contact hypersensitivity response and were refractory to UV
induced immune suppression. In conclusion, SPARC appears to have a crucial role in mediating tumor formation in
response to UV irradiation.
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SPARC (Secreted Protein Acidic and Rich in Cysteine), also
known as osteonectin, BM-40, and 43K protein, is a mul-
tifunctional 32 kDa Ca2þ -binding glycoprotein belonging to
a group of matricellular proteins that mediate cell–extracel-
lular matrix (ECM) interactions but do not serve predomi-
nantly structural roles (Bornstein, 1995; Brekken and Sage,
2001). SPARC is expressed during many stages of devel-
opment in a variety of organisms but is restricted in adult
vertebrates primarily to tissues that undergo consistent
turnover or remodeling. It was first described by three dif-
ferent groups (Sage et al, 1981; Termine et al, 1981; Dziadek
et al, 1986) as a major constituent of bovine and human
bone, and as a protein secreted by a basement membrane
tumor and by proliferating endothelial cells in vitro. Subse-
quently, it has been shown to be expressed by many dif-
ferent cell types (Bradshaw and Sage, 2001). As a regulator
of cell–matrix interactions, SPARC potentially influences
many important physiological and pathological processes
(Brekken and Sage, 2001).
Evidence for the involvement of SPARC in a variety of
cancers is mounting. SPARC overexpression is found in
various human malignancies such as melanoma (Massi
et al, 1999), glioma (Schultz et al, 2002), meningioma, and
hepatocellular, colorectal, and breast carcinomas (Sakai et al,
2001). Moreover, melanoma cells with suppressed expres-
sion of SPARC were no longer able to generate tumors
when injected into athymic mice, but control melanoma
cells showed 100% tumorigenicity (Ledda et al, 1997). An-
giogenesis, the growth of new vessels from extant
vasculature, includes endothelial cell invasion and ECM re-
modeling and is a major factor in tumor growth and metas-
tasis. SPARC has been shown to be associated with
growing vessels in the chick chorioallantoic membrane
and was localized to the tips of the growing vessels (Iruela-
Arispe et al, 1995).
Similar to wound healing, substantial ECM turnover and
rearrangement also occur during tissue invasion by tumor
cells. High levels of SPARC are often associated with met-
astatic tumors (Brekken and Sage, 2001). SPARC induces
expression of plasminogen activator inhibitor-1 (Hasselaar
et al, 1991) and the matrix metalloproteinases (MMPs) col-
lagenase (MMP-1), stromelysin (MMP-3), and 92 kDa gel-
atinase (MMP-9), which are implicated in the degradation of
basement membranes and ECM (Tremble et al, 1993). This
degradation is an essential process for invasion and me-
tastasis in human malignancies (Sakai et al, 2001).
Chronic exposure of the skin to ultraviolet (UV) radiation
causes destructive changes in the connective tissue ele-
ments of the skin and is the major cause of non-melanoma
skin cancer. In addition to the emergence of skin tumors,
the epidermal layer increases in thickness, there are mod-
ifications in dermal collagen, and there is a substantial ac-
cumulation of elastic fibers (solar elastosis) (Kligman et al,
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1982; Bissett et al, 1987; Starcher et al, 1996). Squamous
cell carcinomas (SCC) are the predominant tumor class in
hairless mice exposed to UV radiation (Nishigori et al, 1992),
and represent one of the most common skin cancers as-
sociated with a substantial risk of metastasis in humans. It
is widely accepted that normal keratinocytes in the epider-
mis can convert to SCCs through a multi-step process that
involves activation of proto-oncogenes and/or inactivation
of tumor suppressor genes (Kubo et al, 2002). It now ap-
pears that ECM as well as matricellular proteins may be
important signaling molecules in regulating the malignancy
of tumor cells (Radisky et al, 2002). In the present study we
investigated the potential effect(s) of SPARC in UV-induced
cancer in hairless SPARC-null mice. Unlike the subcutane-
ous and mammary tumor models described in the two
published studies of tumor growth in SPARC-null animals
(Brekken et al, 2003; Sangaletti et al, 2003), UV-irradiated
hairless mice represent a different model of tumor induction
that includes epidermal hyperplasia and increased dermal
angiogenesis (Kajiya et al, 2004).
Results
Breeding of hairless SPARC-null mice The crossbreed-
ing of SPARC-null mice to SKH-1 hairless mice was suc-
cessful and produced an F1 generation heterozygous for the
hairless phenotype and SPARC-null allele. The F2 genera-
tion had all genotypic combinations with respect to the
hairless and SPARC-null traits. SKH-1/Hairless SPARC-null
(/) mice appeared normal and healthy except for early
cataractogenesis and a 15% lower body weight compared
to SKH-1 (þ /þ ) mice. Gels used to determine genotype
indicated a single 500 bp band in SPARC-null mice, a single
band at 300 bp in SKH-1 mice, and both bands in hetero-
zygotes (data not shown).
Tumor count and measurement of skin thickness On the
18th week, after 9.2 J per cm2 of cumulative UVB, tumors
started to form on the exposed backs of SKH-1 mice. By
the end of that week all 20 SKH-1 mice had developed
tumors. The SKH-1/SPARC-null mice showed no tumor for-
mation at this point. On the 21st week, after 13.5 J per cm2
of cumulative UVB, a small number of papillomas started to
form on the backs of six SPARC-null mice. By the end of the
experiment, however, no additional mice developed tumors.
The number, size, and severity of tumors on SKH-1 mice
continued to increase until the end point at 23 weeks, at
which time there was a striking difference in tumor forma-
tion and development between SKH-1 and SKH-1/SPARC-
null mice (Fig 1). The total tumor count, with tumors grouped
as either o2 mm or 42 mm, for SKH-1 and for SKH-1/
SPARC-null mice is shown in Fig 2. No tumors larger than
2 mm developed on any SPARC-null mice under the con-
ditions of this experiment. The appearance of the skin was
typical for SKH-1 mice receiving UV irradiation, with thick-
ening and wrinkling of the skin. The skin of the SKH-1/SP-
ARC-null mice showed much less gross pathology. One
SPARC-null mouse developed a severe wound on its back
during the 22nd week and was euthanized. All 20 SKH-1
mice receiving UV developed tumors of uniform severity;
however, only six of the 19 SKH-1/SPARC-null mice receiv-
ing UV showed any changes, all of which were very minor
papillomas. None of the mice in either the SKH-1 or SKH-1/
SPARC-null non-irradiated control groups developed
tumors spontaneously.
Histology of skin and tumors Histologically, there was a
noticeable increase in the amount of elastic fibers in the
upper dermis when UV-exposed animals were compared to
Figure1
Tumor development on mice exposed to 13.2 J per cm2 over a
period of 23 wk. SKH-1/SPARC-null mouse (/) on the right and
SKH-1 (þ /þ ) on the left. A typical small papilloma is shown on the
back of the / mouse (arrow), whereas multiple large and small
tumors are present on the (þ /þ ) mouse. Also notice the thicker skin
folds on the neck and above the eyes on the (þ /þ ) mouse compared
to the (/).
Figure2
Total number of tumors on the backs of mice exposed to UV ir-
radiation. Tumors are divided into papillomas (o2 mm) (solid bar) and
large (42 mm) squamous cell carcinomas (hatched bar). n¼ 20 for the
SKH-1 and 19 for the SKH-1/SPARC-null. Differences between SKH-1
and SKH-1/SPARC-null were highly significant (po0.001). Numbers on
each bar represent precise value of y-axis.
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their respective controls in both the SKH-1 and SKH-1/
SPARC-null groups (Fig 3). Control skin from both the SKH-
1 and SKH-1/SPARC-null animals showed fine, scattered
elastic fibers originating from the cells lining the hair follicles
(Fig 3a and c). When the SKH-1 mice were exposed to UV,
there was a conspicuous thickening of the elastic fibers,
and they also appeared to lengthen considerably, extending
as long straight fibers from hair follicle to adjoining follicle
(Fig 3b). This characteristic was true for much of the UV-
irradiated SKH-1/SPARC-null skin, except for the presence
of patches of random, curled elastic fibers (Fig 3d). These
disorganized areas of elastic fibers were observed in all of
the SKH-1/SPARC-null mice exposed to UV irradiation and
were most evident in the subepithelial upper dermis to the
level of emergence of the sebaceous glands. The SKH-1
non -irradiated control skin was somewhat thicker than
SKH-1/SPARC-null control samples, due primarily to the
presence of a greater number of adipocytes, which, after
tissue processing, were seen as small void areas in the
lower dermis. This difference was even more evident in the
UV-exposed skin, as horn-containing dermal cysts ap-
peared to increase in size and to form multiple rows, to a
greater extent in the SKH-1 skin than in the SKH-1/SPARC-
null skin. In response to UV, the influx of inflammatory cells
into the dermis, as well as epidermal hyperplasia, was not
different between the SKH-1 and SKH-1/SPARC-null ani-
mals. Measurement of epidermal and dermal thickness of
the processed skin showed that the epidermis and dermis
were both increased in SKH-1 and SKH-1/SPARC-null mice
in response to UV (Table I). The epidermal increase following
UV irradiation was equivalent between SKH-1 and SKH-1/
SPARC-null groups and was significantly different from the
non-irradiated skin (po.01). The dermis was only slightly
increased in thickness, although consistent with previous
reports, SPARC-null dermis was thinner than that of the
corresponding wild-type animals (Bradshaw et al, 2003).
The larger tumors found in the SKH-1 irradiated skin
displayed severely dysplastic epithelia, characteristic of
non-invasive in situ squamous cell carcinoma. Immuno-
histochemistry to detect the presence of the SPARC protein
in SKH-1 skin and tumors is shown in Fig 3e. SPARC was
undetectable in skin from the non-irradiated control group,
but it was present in basal and superficial areas of the tumor
mass, as indicated by the red peroxidase reaction. SPARC
was seen associated not with the cancerous keratinocytes
of the epithelium but in the underlying dermis. The spindle-
shaped cells staining for SPARC were unreactive with anti-
VEGF R2 antibody, a result indicating that these cells were
not endothelial cells. In this area of the tumor, only one
capillary was present showing a positive reaction for end-
othelial cells (arrow) (Fig 3).
Measurement of skin matrix proteins The total protein in
milligrams per unit area for each experimental group is
shown in Fig 4a. Total protein for both UV-exposed groups
increased significantly (po0.001) when compared to con-
trols. Levels increased proportionally following UV irradia-
tion in both the SKH-1 and SKH-1/SPARC-null groups. The
quantity of elastin expressed as the amount of desmosine
per unit area of skin for each group is shown in Fig 4b.
Desmosine increased significantly (po0.001) in the UV-
Figure 3
Elastic fiber staining of sections of skin from control and UV-irra-
diated mice. Sections from SKH-1 control (non-irradiated) (a) and UV-
irradiated (b) skin, compared with similar sections from SKH-1/SPARC-
null control (c) and UV-irradiated mice (d). Sections were stained with
Hart’s elastic stain and counterstained with tartrazine. Images are from
en face sections. Immunohistochemistry for detection of SPARC in a
tumor from SKH-1 mice (e). SPARC protein (red) is prominently dis-
played in spindle-shaped cells just below the epidermis in the tumor
area (arrow) and also in the dermis on the lower side of the tumor. Inset
rectangle indicates area of the skin shown in the enlarged image. Re-
action of tumor with anti-VEGF R2 antibody is shown in (f). The only
endothelial cell positive staining in this area was around a single cap-
illary (arrow). Scale bars: a–d¼ 25 mm; e, f¼ 40 mm.
Table I. UV irradiation increases skin thickness in SKH-1 and SKH-1/SPARC-null micea
Epidermis (mm) Dermis (mm)
Control UV Control UV
SKH1 25.0þ 2.4 93.7þ 16.6 467.4þ55.3 558.0þ 92.4
SKH-1/SPARC-null 25.6þ 2.7 95.0þ 20.2 357.8þ77.3 403.7þ 64.7
aEach value represents the average and standard deviation. N¼ 19 for SKH-1 and 20 for SKH-1/SPARC-null mice.
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exposed groups compared to their corresponding controls.
The relative increase in desmosine was the same for both
groups. Collagen, expressed as the amount of hydroxypro-
line per unit area for each group, is shown in Fig 4c. Skin
samples from SKH-1/SPARC-null mice had significantly less
collagen than the SKH-1 mice in both the non-irradiated
(control) and UV-irradiated skin. There was also a small but
not significant decrease in collagen levels in the UV-treated
groups compared to their respective controls.
Serum TGF-b1 levels Values obtained for serum TGF-b1
levels of the SKH-1 mice averaged 6.87þ 0.52 ng per mL,
whereas the SKH-1/SPARC-null sera averaged 6.19þ 0.34
ng per mL. Although the differences were small, they were
statistically significant, po0.022.
Contact hypersensitivity (CHS) response is lower in
SPARC-null mice SKH-1 and SKH-1/SPARC-null mice
that were immunized with oxazolone and subsequently
challenged on the ears demonstrated a significant CHS
response, as defined by ear swelling (Fig 5). There were,
however, marked differences in response between the SKH-
1 and SKH-1/SPARC-null mice. In the first experiment (Fig
Figure 4
Changes in biochemical markers in the skin following UV irradi-
ation. Total protein (a), desmosine (b), and hydroxyproline (c) represent
the average and standard deviation from three 3 mm pooled biopsy
punches from each skin. n¼20 for SKH-1 and 19 for the SKH-1/
SPARC-null groups. When UV groups were compared to their respec-
tive non-irradiated controls, the difference was highly significant,
po0.001 for protein and desmosine. Differences were not significant
for hydroxyproline.
Figure5
UV-induced immunosuppression in SKH-1 and SKH-1/SPARC-null
mice. Contact hypersensitivity response to oxazolone. Immunization
was induced with 150 mg oxazolone (a) or 300 mg oxazolone (b). Mean
ear swelling was measured after challenge with 100 mg oxazolone.
Immunosuppression was induced with 25 J per cm2 (a) or 65 J per cm2
(b). Solid bars are non-irradiated and hatched bars represent UV-irra-
diated mice. Each value represents the mean and standard deviation.
n¼ 10 mice in each group.
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5a), the mice received a single, moderate dose (0.25 J per
cm2) of UVB and a moderate immunizing dose of oxazolone
(130 mg). UVB irradiation, prior to immunization, suppressed
the induction of CHS responses in the SKH-1 mice about
50%. In contrast, the SKH-1/SPARC-null mice exhibited a
slightly lower CHS response, and no immunosuppression
occurred following UVB irradiation. The experiment was
repeated with mice receiving two higher UV exposures
(2  0.67 J per cm2) and immunized with twice the dose
of oxazolone (Fig 5b). The CHS response was greater with
the higher dose of oxazolone; however, the overall results
were comparable. The SKH-1 mice showed a 50% reduc-
tion in CHS response when exposed to UVB, whereas the
SKH-1/SPARC-null mice showed no immunosuppressive
effects in response to UV irradiation.
Discussion
The striking difference in the onset, progression, and se-
verity of tumor formation between SKH-1/SPARC-null and
SKH-1 mice indicates that SPARC has a significant role in
tumorigenesis of UVB-induced skin cancer. The substantial
reduction in tumor formation and delayed onset in SKH-1/
SPARC-null mice indicate that the presence of SPARC pro-
motes tumorigenesis in this model. This result is in agree-
ment with other findings that relate SPARC to various
malignancies. In thin cutaneous malignant melanomas,
SPARC detected by immunohistochemical staining was
correlated positively with clinical outcome and other clin-
icopathologic parameters (Massi et al, 1999). These inves-
tigators concluded that SPARC expression is a predictor of
clinical outcome in thin cutaneous melanomas. SPARC has
also been proposed as a diagnostic marker of invasive
meningiomas (Rempel et al, 1999).
Of the few small papillomas we observed on SKH-1/
SPARC-null mice, none was metastatic. Evidence from the
investigation of glioma invasion in rats suggests that, in the
absence of SPARC, tumors would be even less likely to
metastasize. Using a rat/astrocytoma model, Schultz et al
(2002) showed that SPARC contributes to brain tumor in-
vasion, and that the effects of SPARC are related to the
levels of SPARC secreted into the ECM and the resultant
modulation of cell adhesion and motility. The evidence
showing that SPARC was not expressed by the cancerous
keratinocytes in UV-induced SSC in our study points to an
indirect role for SPARC in the formation and progression of
these tumors, perhaps through growth factor modulation via
the ECM. Undefined host factors from stromal cells could
stimulate tumor growth. Since it has been proposed that
signals originating from tumor cells regulate SPARC ex-
pression in neighboring fibroblasts, SPARC secreted from
stromal cells could influence neoplastic progression in a
paracrine fashion (Sakai et al, 2001).
The reduced tumorigenesis that we observed in SKH-1/
SPARC-null mice could reflect a decrease in TGF-b1 levels,
given evidence that mesangial cells from SPARC-null mice
express decreased levels of TGF-b1 mRNA and protein in
comparison with wild-type cells (Bradshaw and Sage,
2001). We in fact found that serum TGF-b1 levels were
lower in the SKH-1/SPARC-null mice compared to the SKH-
1 mice. These differences, although reaching significance,
were minimal, and it is unlikely that this level of change in
circulating TGF-b1 would be a major contributor to the
striking differences we observed in tumor susceptibility.
Mechanisms have been proposed for the increased
amount of elastin seen in response to UV, or solar elastosis.
The generation of free radicals plays a role in cutaneous
alterations resulting from UV (Bernstein, 2002). Reactive
oxygen species may form as a result of UV exposure or may
result from the inflammatory response following UV-induced
injury, even in the absence of erythema. Elastin promoter
activation by reactive oxygen species in fibroblasts derived
from mouse skin has been demonstrated (Bernstein, 2002),
and might play a role in the generation of solar elastosis in
photoaged skin.
The absence of SPARC from the dermal stroma/ECM did
not appear to affect the overall responses to UV radiation,
such as increased elastin production, a decrease in colla-
gen content, epidermal hyperplasia, and influx of inflam-
matory cells. These effects were observed in both the
SKH-1 and SKH-1/SPARC-null mice and are well charac-
terized in the UV hairless mouse model. UVB irradiation
stimulates the synthesis of tropoelastin mRNA (Seo et al,
2001) and the deposition of new dermal elastic fibers in the
skin of humans and experimental animals (Kligman et al,
1982; Starcher et al, 1999). This was the case here, as in-
creased elastic fibers were observed histologically, and
increased elastin was confirmed by quantification of des-
mosine. There were areas of the SKH-1/SPARC-null skin,
however, which showed aberrant deposition or assembly
of the UV-induced elastic fibers, in contrast to the usual
organized array observed with SKH-1 mice. These disor-
ganized elastic fibers were not observed in the SKH-1/
SPARC-null mice prior to UV irradiation. The role of SPARC
in elastin assembly during pathological elastogenesis in
adult mice stimulated by UV irradiation is not known.
Since there was such a prominent increase in total skin
protein following UV irradiation, skin area was used as the
denominator to prevent masking of changes that might oc-
cur. That the skin of SKH-1/SPARC-null and SKH-1 groups
increased in total protein content equally indicated that the
net protein degradation, synthesis, and cellular influx were
equivalent. The collagen content of the skin of the SKH-1/
SPARC-null mice was significantly less compared to that of
SKH-1 mice. There was also a slight decrease in collagen
in both groups following UV irradiation, in agreement with
other studies (Kligman et al, 1982, 1985). MMPs and their
inhibitors regulate the degradative pathway of extracellular
collagen. UV irradiation has been reported to stimulate col-
lagenase (MMP-1) synthesis by human skin fibroblasts, an
effect contributing to collagen degradation that leads to
photoageing (Miyachi and Ishikawa, 1998).
The increase in skin thickness in UV-exposed mice was
due primarily to keratinocyte hyperplasia, influx of inflamma-
tory cells into the dermis, and proliferation and ‘‘stacking’’ of
dermal cysts. SKH-1/SPARC-null control (non-irradiated)
skin was thinner than SKH-1 control skin because of what
appeared to be fewer adipocytes and significantly less der-
mal collagen. The increased stacking of dermal cysts, seen
primarily in SKH-1 skin, has been reported to reach four to
five rows (Kligman et al, 1982).
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UV irradiation is known to contribute directly to tumor
initiation. UV may also act indirectly by suppression of the
immune response. In these studies we used two levels of
UV and antigen, and in both instances we observed that the
SKH-1/SPARC-null mice were resistant to UVB-induced
immunosuppression. It was also notable that the non-irra-
diated SKH-1/SPARC-null mice exhibited a significantly
reduced CHS response. Immunosuppression has been
considered a risk factor in tumor development; however,
earlier studies have shown that nude mice, with a compro-
mised immune system, developed UVB-induced tumors
in a manner similar to mice with a reconstituted thymus
(Norbury and Kripke, 1978; Hoover et al, 1987). Resistance
to immunosuppression may have been a contributing factor
in the SKH-1/SPARC-null mice, but other factors are prob-
ably of equal importance. Resistance to UVB immune sup-
pression has been shown to be mediated by tumor necrosis
factor (TNF)-a (Yoshikawa and Streilein, 1990) through the
TNF-a receptor (Wang et al, 1997). Transgenic TNF receptor
2-null mice have also been shown to be resistant to UVB-
induced tumor induction in much the same manner that we
observed with the SKH-1/SPARC-null mice (Starcher, 2000).
To date, however, there is no evidence that the anti-tumor
effects of SPARC in this model are mediated through TNF-a.
Enhanced tumor growth in UV-irradiated skin has been
shown to be associated with an influx of inflammatory cells
into the epidermis (Sluyter and Halliday, 2000). These in-
vestigators suggested that, in their model, immunosup-
pression did not appear to be responsible for enhanced
tumor growth, but inflammatory infiltrates could have con-
tributed to the promotion of tumor growth in the skin. In our
study, immunohistochemistry of tumors showed that
SPARC was localized to the region of dermis underlying
the cancerous keratinocytes. Consistent with other reports,
most of the cells producing SPARC appeared to be fibro-
blasts (Brekken and Sage, 2001; Puolakkainen et al, 2003).
It is also likely that SPARC secreted by cellular infiltrates
(e,g., macrophages) is an important factor in tumor promo-
tion (Brekken et al, 2003; Sangaletti et al, 2003).
To date there are two publications describing the growth
of tumors in SPARC-null mice. Brekken et al (2003) showed
that subcutaneously implanted Lewis lung carcinoma and
B-cell lymphoma were significantly larger in animals lacking
SPARC, due primarily to a compromised tumor stromal
ECM, failure of the tumor to encaplsulate, and reduction of
macrophage infiltration. In apparent contrast, Sangaletti
et al (2003) described smaller mammary tumors in SPARC-
null mice backcrossed onto a BALB/c genetic background,
accompanied by an enhanced infiltration of inflammatory
leukocytes. In both reports it was clear that host-derived
SPARC influenced the growth of these tumors. The differ-
ential effects are likely due to the immediate tumor envi-
ronment, and not to the tumor cells themselves (Framson
and Sage, 2004). The SKH-1 UV-irradiation model is clearly
different from either of the studies cited above. That the
tumors failed to form in the absence of SPARC indicates
that the alterations in dermal ECM (e.g., collagen) typical of
SPARC-null mice might not be the determining factors in
UV-induced tumor induction in these animals (Brekken et al,
2003). Similarly, the diminished CHS response and resist-
ance to immunosuppression are suggestive of effects of
SPARC on immune cell recruitment and/or activation, as
described by Sangaletti et al (2003).
In summary, we show that skin tumor formation in re-
sponse to UVB irradiation is substantially reduced in SKH-1/
SPARC-null mice. These mice also appear to have a limited
CHS response and are refractory to UVB immune suppres-
sion. Morphometric and connective tissue changes that nor-
mally occur following UV exposure were not affected by the
SPARC mutation. We propose that SPARC has a critical role
in mediating tumor formation in response to UV irradiation.
Materials and Methods
Breeding of hairless SPARC-null mice SPARC-null mice
(129SV  C57Bl6/J) (Brekken et al, 2003) were crossed with
SKH-1 hairless mice (Charles River Laboratory, Wilmington, Mas-
sachusetts) to produce an F1 generation. F1 progeny were cross-
bred to produce an F2 generation. At 2 wk of age, F2 mice that
began losing their hair were genotyped using a PCR method to
confirm the absence of the wild-type SPARC gene. Hairless
SPARC-null mice were subsequently crossed for up to eight gen-
erations to produce the female mice used in these experiments.
Genotyping was accomplished by digesting a tail tip from each
mouse and using PCR to detect the SPARC-null allele. The PCR
primers and conditions were: ‘‘SPARC.FOR’’—50 GATGAGGGTGG
TCTGGCCCAGCCCTAGATGCCCCTCAC 30, ‘‘SPARC.REV’’—50
CACCCACACAGCTGGGGGTGATCCAGATAAGCCAAG 30, and
‘‘NEOMYCIN.REV’’—50 GT TGTGCCCAGTCATAGCCGAATAGCCT
CTCCACCCAAG 30 (Sigma Genosys—The Woodlands, TX), 2.5 U
of Taq polymerase (New England Biolabs, Beverly, Massachu-
setts), and sterile water for a final reaction volume of 50 mL. The
PCR was conducted with an icycler (Bio-Rad Laboratories, Her-
cules, California) under the following conditions: initial denaturation
step at 961 C for 5 min, 40 cycles of denaturation at 941C for 30 s,
primer annealing at 701C for 30 s, and extension at 721C for 1 min,
and a final extension step at 721C for 7 min. Primers were designed
such that a 500 bp product indicated the insertional inactivation of
the SPARC gene, and a 300 bp product indicated a normal SPARC
gene. PCR product size was approximated on agarose gels by
comparison to a 100 bp DNA ladder (New England Biolabs). Digital
images of gels were made with a Bio-Rad Gel Doc 2000.
UV irradiation of mice and tumor count UV irradiation was in-
itiated when the hairless SPARC-null female mice reached 6 wk of
age. For controls, we used 30 age-matched SKH-1 hairless female
mice. Filtered UV irradiation approximating the sun spectrum (10%
UVB, 90% UVA) was administered with a 400 W mercury halide
Dermalight (Dermalight Systems, Sherman Oaks, California) The
mice were given three sub-erythemal treatments per week for 22
wk. The actual dose of UVB given per treatment was calculated
from the manufacturers dose chart. The first 11 wk the mice re-
ceived 0.15 J per cm2 UVB per treatment, the next 5 wk 0.23 J per
cm2 UVB per treatment, and the last 7 wk, 0.34 J per cm2 UVB per
treatment. The cumulative UVB administered in the experiment
was 14.5 J per cm2. Mice were housed in a vivarium on a 12 h light/
dark cycle at 251C, and were given food and water ad libitum. One
week after the final UV exposure (23 wk), tumors on the backs of
each mouse were counted and grouped as either o2 mM or 42
mM. All animal experimentation conformed to institutional guide-
lines.
Histology of skin and tumors The mice were euthanized by cer-
vical dislocation, and a section of skin was removed from the back
of each animal and fixed in Excell (American MasterTech Scien-
tific, Lodi, California) for 24 h. Samples for histology were taken
from non-tumor and tumor-containing areas of skin with a 4 mm
biopsy punch. Tumors were excised with a razor blade and cut in
half prior to embedding. All samples were dehydrated through
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alcohol and xylene and were embedded in paraffin. Ten microm-
eter en face sections of non-tumor skin, as well as 7 mm sagittal
sections of tumor and non-tumor skin, were placed on slides,
stained to visualize elastin using a modified Hart’s elastin stain
(Starcher and Conrad, 1995), and counterstained with tartrazine.
Sections used to visualize collagen were incubated in saturated
picric acid for 1 h at 651C and were stained with Gomori’s tri-
chrome for 20 min. Tumors were visualized by staining in Gill’s
hematoxylin and eosin. Tumor specimens were categorized in
terms of SCC or papilloma by the Pathology Department at the
University of Texas Health Center at Tyler. Epidermal and dermal
thickness of processed tissue was determined using a Lasico (Los
Angeles, California) field-of-view micrometer. Sagittal sections of
tumors and non-irradiated SKH-1 skin were analyzed for SPARC
expression by immunohistochemistry using goat anti-mouse
SPARC antibody (R & D Systems, Minneapolis, Minnesota) and
AEC substrate (Innovex Biosciences, Richmond, California). Con-
trast Blue (Kirkegaard & Perry Laboratories, Gaithersburg, Mary-
land) was used as the counterstain. Endothelial cells were stained
with anti-VEGF R2 (KDR/Flk-1) antibody, a generous gift from Dr
Rolf A. Brekken, (UT Southwestern Medical Center, Dallas, TX.)
Measurement of skin matrix proteins For biochemical measure-
ments, three 3 mm biopsy punches were removed from three dif-
ferent non-tumor containing areas of fixed skin and placed in 1.5
mL secure lock microfuge tubes. The tissue was hydrolyzed in 0.5
mL of 6 N HCl at 1001C for 24 h, evaporated to dryness under
vacuum with a Savant Speed Vac Concentrator (Holbrook, New
York), and resuspended in 500 mL of water. Total protein was as-
sayed using the ninhydrin-based method described previously
(Starcher, 2001). Elastin was estimated by quantifying desmosine
by radioimmunoassay (Starcher and Conrad, 1995). Collagen was
estimated by measuring hydroxyproline on a Beckman 6300 amino
acid analyzer.
Serum levels of TGF-b Blood was obtained from the orbital vein
of 6 SPARC-null and 8 SKH-1 hairless mice. Serum (2.5 mL) was
activated and assayed according to the manufacturer’s instruc-
tions using the quantikine human TGF-b1 kit (R&D Systems).
Contact hypersensitivity (CHS) The backs of the SPARC-null
and SKH-1 mice were exposed to either a single dose of 0.25 J per
cm2 UVB or two consecutive doses of 0.65 J per cm2 with the
Dermalight. After 5 d, groups of irradiated and non-irradiated con-
trols were immunized by painting 30 ml of a solution of acetone/
corn oil (4:1) containing either 150 or 300 mg of oxazolone on the
stomach. Five days following immunization, all groups were chal-
lenged with 10 mL of 1% oxazolone on each side of one ear. After
24 h, the thickness of the ears was measured with a digital mi-
crometer. The thickness of the non-challenged ear was subtracted
from the thickness of the challenged ear to obtain the CHS value.
Statistical analysis Probability values were acquired using a Stu-
dent’s t test in Microsoft Excel. p-Values of less than 0.05 were
considered significant.
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